Announcements Trials
Browse Landscape

Status

No longer available 2Available 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 321Observational 11Expanded_access 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Solid Tumors 3Rhabdoid Tumor 2Wilms Tumor 1Solid Tumours 1Solid Tumor, Adult 1Solid Tumor Metastatic Cancer Advanced Cancer 1Solid Tumor 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Mesothelioma, Malignant 1Mesothelioma 1Meningeal Neoplasms 1Medulloblastoma 1Malignant Solid Tumour 1Hepatoblastoma 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Carcinoma, Renal Cell 1Advanced Solid Tumor Cancer 1

Interventions

pazopanib 1carotuximab 1Capecitabine 1Bevacizumab 1Axitinib 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Expanded_access × Solid Tumors × Other solid neoplasm × Clear all
NCT05982873 2026-02-06

Expanded Access to Telisotuzumab Adizutecan

AbbVie

Available
Other solid neoplasm

Solid Tumors

NCT05107193 2022-11-08

Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors)

Boehringer Ingelheim

No longer available
Other solid neoplasm

Solid Tumors

NCT02354612 2021-02-15

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Tracon Pharmaceuticals Inc.

No longer available
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡